Clinical Trial

Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients

Completed
View on ClinicalTrials.gov →
Summary
Compared to the general population, diabetic patients have a significantly higher rate of inadequate bowel preparation. The European Society of Gastrointestinal Endoscopy (ESGE) guideline recommends polyethylene glycol (PEG) as the preferred bowel-cleansing agent, but there is currently no standardized bowel preparation protocol specifically for diabetic patients. Previous studies have shown that oral lactulose-based regimens or adding lactulose to the standard PEG protocol can improve bowel preparation quality, reduce adverse effects such as abdominal pain, bloating, nausea, and vomiting, and have no impact on blood glucose levels in diabetic patients after consuming 20g or 30g of lactulose. Herein, a multicenter randomized controlled trial(RCT) has been designed to explore the efficacy and safety of lactulose combined with polyethylene glycol electrolyte solution (PEG-ELS) for bowel preparation in patients with type II diabetes mellitus.
Protocol Amendment History 4 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-07-24
notable Enrollment increased: 254 -> 300 participants 2026-07-24
notable Primary completion pushed: 2026-01-25 -> 2026-05-18 2026-07-24
minor Completion moved earlier: 2026-07-25 -> 2026-05-18 2026-07-24
Trial Details
NCT Number NCT07084350
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Type II Diabetes Mellitus
Enrollment 300 participants
Start Date 2025-09-04
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-05-18 (estimated)
Updated on ClinicalTrials.gov 2026-07-23